Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
Top Cited Papers
- 1 April 2016
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 15 (4) , 307-324
Abstract
No abstract availableKeywords
Funding Information
- Multiple Sclerosis Research Australia
- Trish MS Research Foundation (Australia)
- Star Scientific Foundation (Australia)
- Petre Foundation (Australia)
- National Health and Medical Research Council (Australia)
This publication has 133 references indexed in Scilit:
- Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitisBMC Neurology, 2013
- Autoantigen Conformation Influences Both B- and T-cell Responses and EncephalitogenicityJournal of Biological Chemistry, 2012
- Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceJournal of Neuroinflammation, 2010
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Neurofascin as a novel target for autoantibody-mediated axonal injuryJournal of Experimental Medicine, 2007
- Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNature Medicine, 2007
- Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosisProceedings of the National Academy of Sciences, 2006
- Myelin oligodendrocyte glycoprotein–specific T and B cells cooperate to induce a Devic-like disease in miceJournal of Clinical Investigation, 2006
- Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperationJournal of Clinical Investigation, 2006
- Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating eventJournal of Neurology, Neurosurgery & Psychiatry, 2006